• Aucun résultat trouvé

Infermiera/e ______________________________ DATA__________/_______/__________ REPARTO______________________________________ LT

N/A
N/A
Info
Télécharger
Protected

Academic year: 2022

Partager "Infermiera/e ______________________________ DATA__________/_______/__________ REPARTO______________________________________ LT"

Copied!
1
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

Infermiera/e ______________________________ DATA__________/_______/__________ REPARTO______________________________________

LT : ______/Nome___________________ Medicazioni : _____________________________________________________________Cat.Vesc._____/_____

PA_________/______- FC________bpm Altro_______________________________________________________________________CVC ______/_____

TC________°C - SPO2_______________ ___________________________________________________________________________ CVP______/_____

DTX__________mg/dl – ALVO______/____ __________________________________________________________________________T. I.__________ml/h LT : ______/Nome___________________ Medicazioni : _____________________________________________________________Cat.Vesc._____/_____

PA_________/______- FC________bpm Altro_______________________________________________________________________CVC ______/_____

TC________°C - SPO2_______________ ___________________________________________________________________________ CVP______/_____

DTX__________mg/dl – ALVO______/____ __________________________________________________________________________T. I.__________ml/h LT : ______/Nome___________________ Medicazioni : _____________________________________________________________Cat.Vesc._____/_____

PA_________/______- FC________bpm Altro_______________________________________________________________________CVC ______/_____

TC________°C - SPO2_______________ ___________________________________________________________________________ CVP______/_____

DTX__________mg/dl – ALVO______/____ __________________________________________________________________________T. I.__________ml/h LT : ______/Nome___________________ Medicazioni : _____________________________________________________________Cat.Vesc._____/_____

PA_________/______- FC________bpm Altro_______________________________________________________________________CVC ______/_____

TC________°C - SPO2_______________ ___________________________________________________________________________ CVP______/_____

DTX__________mg/dl – ALVO______/____ __________________________________________________________________________T. I.__________ml/h LT : ______/Nome___________________ Medicazioni : _____________________________________________________________Cat.Vesc._____/_____

PA_________/______- FC________bpm Altro_______________________________________________________________________CVC ______/_____

TC________°C - SPO2_______________ ___________________________________________________________________________ CVP______/_____

DTX__________mg/dl – ALVO______/____ __________________________________________________________________________T. I.__________ml/h LT : ______/Nome___________________ Medicazioni : _____________________________________________________________Cat.Vesc._____/_____

PA_________/______- FC________bpm Altro_______________________________________________________________________CVC ______/_____

TC________°C - SPO2_______________ ___________________________________________________________________________ CVP______/_____

DTX__________mg/dl – ALVO______/____ __________________________________________________________________________T. I.__________ml/h LT : ______/Nome___________________ Medicazioni : _____________________________________________________________Cat.Vesc._____/_____

PA_________/______- FC________bpm Altro_______________________________________________________________________CVC ______/_____

TC________°C - SPO2_______________ ___________________________________________________________________________ CVP______/_____

DTX__________mg/dl – ALVO______/____ __________________________________________________________________________T. I.__________ml/h LT : ______/Nome___________________ Medicazioni : _____________________________________________________________Cat.Vesc._____/_____

PA_________/______- FC________bpm Altro_______________________________________________________________________CVC ______/_____

TC________°C - SPO2_______________ ___________________________________________________________________________ CVP______/_____

DTX__________mg/dl – ALVO______/____ __________________________________________________________________________T. I.__________ml/h LT : ______/Nome___________________ Medicazioni : _____________________________________________________________Cat.Vesc._____/_____

PA_________/______- FC________bpm Altro_______________________________________________________________________CVC ______/_____

TC________°C - SPO2_______________ ___________________________________________________________________________ CVP______/_____

DTX__________mg/dl – ALVO______/____ __________________________________________________________________________T. I.__________ml/h

Références

Télécharger maintenant ( PDF - 1 Page - 169.81 KB )

Documents relatifs

W O R LD H E A LT H ORGANIZATION

Co-ordinated comparative studies on cardiovascular diseases are being initiated because of the light they may throw on problems in human cardiology, A Scientific Group composed

W O R LD H E A LT H ORGANIZATION

pourcentage des dépenses concernant les nouveaux projets ne renseignaient qu ! impar- faitement car lis indiquaient seulement que le programme envisagé pour 19бЗ restait assez

H E A LT H TA X E S : A P R I M E R

Sugary drinks: Fiscal policies that lead to at least a 20% increase in the retail price of sugary drinks would result in significant reductions in consumption of such

W O R LD H E A LT H ORGANIZATION

The Regional Committee expressed some concern at the number of unfilled technical posts in the Regional Office and felt that national administrations should be made aware.. o f t h e

W O R LD H E A LT H ORGANIZATION

Le risque d'importation de la variole persistera tant que cette maladie sera endémique dans plusieurs pays du monde. Ce risque s'est apparemment accru ces der- nières années par

&‹:†r‹’Œ:–F‘”†rš„<‘‰Œ(†rˆ–FŽŒ’‹:†¤c…‡–F

[r]

d <c“VbkGn”‚k6IHRvRBIPAQh<?RBIHkGFA•JI^–—RBIKMFq0<?XY€"w Œ IPADC™˜š@vR+AFbRBZHO6b›šJ6<?R

[r]

†ˆ‡1‰„:Š‹U e„D lt;Ž<˜^™‹U†‡ˆ‹U‡Š‹‘š„:˜C—D„<‡†ˆ‹~˜C

[r]